TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36153559

Group type: EXPERIMENTAL
Intervention: Omitting routine intra-abdominal drainage after distal pancreatectomy (DP)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Routine intra-abdominal drainage after distal pancreatectomy (DP)
Number of subjects: 282
Study: 33264094

Group type: EXPERIMENTAL
Intervention: ShoulderX
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Skelex
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Both exoskeletons
Number of subjects: 4
Study: 34351508

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) in a tumescent solution prior to liposuction
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional liposuction technique
Number of subjects: 50
Study: 32976702

Group type: EXPERIMENTAL
Intervention: Robotic sleeve gastrectomy and robotic‐assisted kidney transplant
Number of subjects: 20

Group type: COMPARATOR
Intervention: Robotic kidney transplant
Number of subjects: 20
Study: 32337834

Group type: EXPERIMENTAL
Intervention: Duplicated six-minute walk test (6MWT)
Number of subjects: 46
Study: 33883288

Group type: EXPERIMENTAL
Intervention: Nordic Walking
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional Walking
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both Nordic Walking and Conventional Walking
Number of subjects: 74
Study: 35735417

Group type: EXPERIMENTAL
Intervention: Self-collection of a vaginal sample for HPV screening
Number of subjects: 13176

Group type: EXPERIMENTAL
Intervention: Participants who agreed that screening with an HPV test instead of a Pap test was acceptable
Number of subjects: 13176

Group type: EXPERIMENTAL
Intervention: Participants who indicated that collecting their own HPV sample was acceptable
Number of subjects: 13176

Group type: EXPERIMENTAL
Intervention: Participants with higher educational ascertainment
Number of subjects: 13176
Study: 33842978

Group type: EXPERIMENTAL
Intervention: Meta Salud Diabetes (MSD) intervention delivered within support groups for 13 weeks
Number of subjects: 518

Group type: COMPARATOR
Intervention: Control group (GAM usual care)
Number of subjects: 518
Study: 32151879

Group type: EXPERIMENTAL
Intervention: 0.65 g/kg alcohol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Redundant multisensory signals
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Redundant unisensory signals
Number of subjects: 20
Study: 35797844

Group type: EXPERIMENTAL
Intervention: Ethyl chloride spray
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 33721359

Group type: EXPERIMENTAL
Intervention: Localized muscle fatigue (induced by an isokinetic fatiguing protocol)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Mental fatigue (induced by the modified incongruent Stroop-word task)
Number of subjects: 58
Study: 35733624

Group type: EXPERIMENTAL
Intervention: TMP‐4 cream
Number of subjects: 199

Group type: COMPARATOR
Intervention: Diclofenac gel
Number of subjects: 199
Study: 35730535

Group type: EXPERIMENTAL
Intervention: Dual use of VERVE® Chews/Discs
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Exclusive use of VERVE® Chews/Discs
Number of subjects: 213

Group type: COMPARATOR
Intervention: Continue smoking (CS)
Number of subjects: 213
Study: 32847403

Group type: EXPERIMENTAL
Intervention: MaxiPost (0.05 mg/min BKCa channel opener)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: MaxiPost
Number of subjects: 21
Study: 35925430

Group type: EXPERIMENTAL
Intervention: NOL-guided intraoperative administration of fentanyl
Number of subjects: 70
Study: 33326678

Group type: EXPERIMENTAL
Intervention: Cruciate fascial incision
Number of subjects: 209

Group type: COMPARATOR
Intervention: Circular incision
Number of subjects: 209

Group type: COMPARATOR
Intervention: Prophylactic mesh
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: All techniques
Number of subjects: 209
Study: 32149114

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope (MAC)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: McGrath video laryngoscope
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: TruView PCD video laryngoscope
Number of subjects: 93
Study: 34987033

Group type: EXPERIMENTAL
Intervention: Oral amoxicillin (50 mg/kg body weight per dose, two times per day for 5 days)
Number of subjects: 3897

Group type: COMPARATOR
Intervention: Control group (referral to health facility)
Number of subjects: 3897

Group type: EXPERIMENTAL
Intervention: Pulse oximetry by CLHWs in intervention clusters
Number of subjects: 3897
Study: 33877707

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D3 (1800 IU/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no supplementation)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low-dose vitamin D3 (700 IU/day)
Number of subjects: 32
Study: 32711853

Group type: EXPERIMENTAL
Intervention: Sucralose consumption at 15% of the acceptable daily intake using commercial sachets added to food
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group followed the same protocol without an intervention
Number of subjects: 60
Study: 34996629

Group type: EXPERIMENTAL
Intervention: Daily teriparatide (TPTD) injections (20 μg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Weekly teriparatide (TPTD) injections (56.5 μg)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard conservative therapy (non-TPTD group)
Number of subjects: 27
Study: 34668331

Group type: EXPERIMENTAL
Intervention: Two doses of 15 mg/kg intravenous TXA postoperatively at 2 and 24 hours after closing the incision (group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: A single dose of 15 mg/kg intravenous TXA 2 hours postoperatively (group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (group C)
Number of subjects: 0
Study: 34593275

Group type: EXPERIMENTAL
Intervention: 20-cm C-UCM
Number of subjects: 76

Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 76
Study: 34547076

Group type: EXPERIMENTAL
Intervention: Freeze-Dried Acellular Dermal Matrix (FDADM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Solvent-Dehydrated Acellular Dermal Matrix (SDADM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both FDADM and SDADM
Number of subjects: 20
Study: 32157797

Group type: EXPERIMENTAL
Intervention: 400 μg misoprostol
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: 800 μg misoprostol
Number of subjects: 523
Study: 35483774

Group type: EXPERIMENTAL
Intervention: OKC
Number of subjects: 41
Study: 36070924

Group type: EXPERIMENTAL
Intervention: Surgical mask with mask fitter
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Surgical mask with micropore tape
Number of subjects: 15

Group type: COMPARATOR
Intervention: N95 mask
Number of subjects: 15

Group type: COMPARATOR
Intervention: Surgical mask alone
Number of subjects: 15
Study: 32302665

Group type: EXPERIMENTAL
Intervention: lixisenatide + basal insulin
Number of subjects: 150

Group type: COMPARATOR
Intervention: sulphonylurea + basal insulin
Number of subjects: 150
Study: 35839004

Group type: EXPERIMENTAL
Intervention: mHealth intervention with personalized feedback for 6 months
Number of subjects: 307

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 307
Study: 34209561

Group type: EXPERIMENTAL
Intervention: FAWGT diet (fruit, avocado, whole grains, and trout)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Diet high in saturated fat and rich in processed carbohydrates
Number of subjects: 44
Study: 35133634

Group type: EXPERIMENTAL
Intervention: m-health-based core stability exercise (CSE) combined with self-compassion training (SCT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: m-health-based core stability exercise (CSE) alone
Number of subjects: 37
Study: 32285582

Group type: EXPERIMENTAL
Intervention: Simplified 5-step hand hygiene programme
Number of subjects: 472

Group type: COMPARATOR
Intervention: Conventional 7-step hand hygiene programme
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 472
Study: 34129830

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting frailty progression
Number of subjects: 3170
Study: 36293799

Group type: EXPERIMENTAL
Intervention: Dietary intervention (12-week reductive diet)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Physical activity intervention (12-week physical activity plan)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 600
Study: 34697092

Group type: EXPERIMENTAL
Intervention: Progression to dialysis
Number of subjects: 386

Group type: COMPARATOR
Intervention: Stable advanced CKD
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Progressed to dialysis
Number of subjects: 386
Study: 36449869

Group type: EXPERIMENTAL
Intervention: Continuous irradiated polyglactin‐910 (IPG) sutures
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Nylon sutures
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Fast-absorbing gut (FG) sutures
Number of subjects: 210

Group type: COMPARATOR
Intervention: Comparison among all suture materials (IPG, nylon, FG)
Number of subjects: 210
Study: 34142743

Group type: EXPERIMENTAL
Intervention: Once-weekly exenatide-LAR injection with weekly nurse review for 20 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard care with weekly nurse review for 20 weeks
Number of subjects: 22
Study: 36049225

Group type: EXPERIMENTAL
Intervention: Spinning exercise (group cycling with music)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Stationary cycling (individual pedaling on a stationary bike)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 35189925

Group type: EXPERIMENTAL
Intervention: UC-MSCs (106 UC-MSCs/kg, three intravenous infusions over 5 days)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl, three intravenous infusions over 5 days)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: UC-MSCs
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 35749148

Group type: EXPERIMENTAL
Intervention: Artificial tear containing carbomer, hyaluronic acid, glycerol, and medium-chain triglycerides
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control artificial tears
Number of subjects: 32
Study: 34656412

Group type: EXPERIMENTAL
Intervention: HIPEC (hyperthermic intraperitoneal chemotherapy)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 252
Study: 32264945

Group type: EXPERIMENTAL
Intervention: Sahaj Samadhi Meditation
Number of subjects: 160

Group type: COMPARATOR
Intervention: Health Enhancement Program
Number of subjects: 160
Study: 35967847

Group type: EXPERIMENTAL
Intervention: ICU-acquired infection
Number of subjects: 16808

Group type: EXPERIMENTAL
Intervention: Nomogram based on independent predictors
Number of subjects: 16808

Group type: COMPARATOR
Intervention: Classical scoring systems (SIRS, SOFA, OASIS, SAPS II, LODS, CCI, APS III)
Number of subjects: 16808
Study: 33309774

Group type: EXPERIMENTAL
Intervention: Cobimetinib plus atezolizumab
Number of subjects: 446

Group type: COMPARATOR
Intervention: Pembrolizumab
Number of subjects: 446
Study: 34452971

Group type: EXPERIMENTAL
Intervention: Bisoprolol once daily (1.25-5 mg, dependent on tolerated dose)
Number of subjects: 1164

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 1164
Study: 35060333

Group type: EXPERIMENTAL
Intervention: Aromatherapy massage with lavender oil for 4 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study: 32449365

Group type: EXPERIMENTAL
Intervention: SMS intervention for ARV retention and adherence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SMS intervention
Number of subjects: 0
Study: 33087078

Group type: EXPERIMENTAL
Intervention: Piano instruction (experimental group)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Musical listening awareness (control group)
Number of subjects: 155
Study: 35473344

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) decoction
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional western medicine treatment
Number of subjects: 120
Study: 33539664

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting personalized post-recurrence survival (PRS)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Nomogram's predictive capacity
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Risk grouping by the nomogram
Number of subjects: 376
Study: 33160281

Group type: EXPERIMENTAL
Intervention: Hemodiafiltration (HDF)
Number of subjects: 195

Group type: COMPARATOR
Intervention: High-flux hemodialysis (HD)
Number of subjects: 195
Study: 35724306

Group type: EXPERIMENTAL
Intervention: Canagliflozin treatment
Number of subjects: 3581
Study: 32268897

Group type: EXPERIMENTAL
Intervention: Oral sodium bicarbonate (up to 3 g/day) for up to 2 years
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 35221104

Group type: EXPERIMENTAL
Intervention: Very early invasive coronary angiography (ICA)
Number of subjects: 2147

Group type: COMPARATOR
Intervention: Standard care (ICA within 48 to 72 hours)
Number of subjects: 2147
Study: 32628436

Group type: EXPERIMENTAL
Intervention: Vaccinated group
Number of subjects: 494

Group type: COMPARATOR
Intervention: Unvaccinated group
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Regular follow-ups
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Knowledge about tetanus vaccine
Number of subjects: 494
Study: 36078842

Group type: EXPERIMENTAL
Intervention: PIVC pack
Number of subjects: 0
Study: 33657976

Group type: EXPERIMENTAL
Intervention: Amiloride/HCTZ
Number of subjects: 10

Group type: COMPARATOR
Intervention: HCTZ
Number of subjects: 10
Study: 32645111

Group type: EXPERIMENTAL
Intervention: Chest-press resistance training (using Smith machine, dumbbells, or Swiss ball)
Number of subjects: 35
Study: 36058618

Group type: EXPERIMENTAL
Intervention: Postmastectomy radiation therapy (RT) with internal mammary nodal irradiation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Postmastectomy radiation therapy (RT) without internal mammary nodal irradiation
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Slice-by-slice analysis of CTVsc + axIII + axII
Number of subjects: 26
Study: 36442021

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 164
Study: 33400963

Group type: EXPERIMENTAL
Intervention: Serum urate (observational analysis)
Number of subjects: 359827

Group type: EXPERIMENTAL
Intervention: Serum urate (2-stage MR analysis)
Number of subjects: 359827

Group type: EXPERIMENTAL
Intervention: Serum urate (2-sample MR analysis)
Number of subjects: 359827
Study: 34407046

Group type: EXPERIMENTAL
Intervention: Pyrotinib plus capecitabine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Capecitabine-only
Number of subjects: 20
Study: 33293047

Group type: EXPERIMENTAL
Intervention: ICB with ultrasound guidance
Number of subjects: 160

Group type: COMPARATOR
Intervention: No Ultrasound guidance
Number of subjects: 160
Study: 35717357

Group type: EXPERIMENTAL
Intervention: Venastent
Number of subjects: 256

Group type: COMPARATOR
Intervention: Zilver stent
Number of subjects: 256
Study: 33002633

Group type: EXPERIMENTAL
Intervention: CBT-based optimizing expectations (EXPECT)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Active control group focusing on emotional support (SUPPORT)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard medical care only (SMC)
Number of subjects: 124
Study: 34120694

Group type: EXPERIMENTAL
Intervention: Video-based patient education
Number of subjects: 89

Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 89
Study: 32981178

Group type: EXPERIMENTAL
Intervention: Increased BMI
Number of subjects: 647

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 647
Study: 36163843

Group type: EXPERIMENTAL
Intervention: Oral-AZA 300mg once-daily for 14 days/28-day cycle
Number of subjects: 472

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Oral-AZA
Number of subjects: 472

Group type: COMPARATOR
Intervention: Non-LT survivors
Number of subjects: 472
Study: 34178834

Group type: EXPERIMENTAL
Intervention: Vitamin D3 50,000 IU intramuscularly monthly for six months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Distilled water (0.25 mL) monthly for six months (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D3 treatment group after 6 months of stopping treatment
Number of subjects: 0
Study: 34528871

Group type: COMPARATOR
Intervention: Control
Number of subjects: 25
Study: 32113648

Group type: EXPERIMENTAL
Intervention: Apolipoprotein A-I (apoA-I) concentrations
Number of subjects: 20370

Group type: EXPERIMENTAL
Intervention: Genetic variant rs12225230
Number of subjects: 20370

Group type: EXPERIMENTAL
Intervention: ApoA-I concentrations (Mendelian randomization)
Number of subjects: 20370
Study: 33884938

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation of markedly incompetent perforators (Group A)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Conventional compression therapy (Group B)
Number of subjects: 119
Study: 32332669

Group type: EXPERIMENTAL
Intervention: Adductor canal block (ACB)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Periarticular infiltration (PAI)
Number of subjects: 120
Study: 33806616

Group type: EXPERIMENTAL
Intervention: Exposure to PM2.5 PAHs in schools within 5 km of the petrochemical industry
Number of subjects: 205

Group type: COMPARATOR
Intervention: Comparative population (children living more than 20 km away from industrial activity)
Number of subjects: 205
Study: 32471186

Group type: EXPERIMENTAL
Intervention: Vitamin E-bonded membranes (VEM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: High-flux same-surface polysulfone dialyzers (Control)
Number of subjects: 80
Study: 35262417

Group type: EXPERIMENTAL
Intervention: Video group (intervention) - practiced skills on the robot simulator with intermediate video revision
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (control) - had intermediate pause instead of video revision
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (video and control) on the da Vinci robot
Number of subjects: 40
Study: 32826657

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 or 10 mg twice daily
Number of subjects: 7061
Study: 32375655

Group type: EXPERIMENTAL
Intervention: Distinct episodes of axial pain separated by more than 6 months
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Axial pain with tendon symptoms within the same year
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Co-occurrence of axial pain and a prescription for nonsteroidal anti-inflammatory drug within 30 days
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Coded episodes of axial pain
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Large joint symptoms and enthesopathy
Number of subjects: 539
Study: 35917265

Group type: EXPERIMENTAL
Intervention: Intradermal Botulinum toxin A injection
Number of subjects: 24

Group type: COMPARATOR
Intervention: Topical 2% glycopyrrolate
Number of subjects: 24
Study: 36253825

Group type: EXPERIMENTAL
Intervention: Gene-corrected autologous keratinocyte grafts (EB-101)
Number of subjects: 7
Study: 32578689

Group type: EXPERIMENTAL
Intervention: Comprehensive multimodal prophylactic intervention for 2 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early, consistent intervention after an initial manic episode
Number of subjects: 0
Study: 33009844

Group type: EXPERIMENTAL
Intervention: Diabetes Education Program based on Tailored interventions and Theory of Planned Behaviour
Number of subjects: 436

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 436
Study: 34370064

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 36005859

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Baseline IGF1
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Baseline IGFBP1
Number of subjects: 414
Study: 34456752

Group type: EXPERIMENTAL
Intervention: Eccentric resistance exercise (10 sets of 5 eccentric unilateral repetitions at 80% of the pre‐determined concentric one repetition maximum)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Seated rest (No‐Ex)
Number of subjects: 29
Study: 33930431

Group type: EXPERIMENTAL
Intervention: Heated tobacco products (HTPs)
Number of subjects: 2038

Group type: EXPERIMENTAL
Intervention: E-cigarettes
Number of subjects: 2038

Group type: EXPERIMENTAL
Intervention: Products without nicotine
Number of subjects: 2038

Group type: EXPERIMENTAL
Intervention: Flavored products
Number of subjects: 2038
Study: 32871985

Group type: EXPERIMENTAL
Intervention: Basic acupuncture and the herbal formulation dangui yinzi
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Danggui yinzi and shu‐stream acupuncture
Number of subjects: 111

Group type: COMPARATOR
Intervention: Danggui yinzi alone
Number of subjects: 111
Study: 33576844

Group type: EXPERIMENTAL
Intervention: Cod (750 g/week)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Salmon (750 g/week)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (normal eating habits, no fish)
Number of subjects: 63
Study: 32450908

Group type: EXPERIMENTAL
Intervention: Bujing Yishi tablets (BJYSP)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Mecobalamin tablets (Control)
Number of subjects: 216
Study: 35511153

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fascial plane block targeting the superior gluteal nerve
Number of subjects: 0
Study: 33621613

Group type: EXPERIMENTAL
Intervention: Goals to increase fruit and vegetable intake
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Goals to decrease unhealthy snack intake
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 203
Study: 32160301

Group type: EXPERIMENTAL
Intervention: H. P. Acthar gel (repository corticotropin injection)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 8
Study: 35932354

Group type: EXPERIMENTAL
Intervention: Greater social support
Number of subjects: 1944

Group type: EXPERIMENTAL
Intervention: Perceived stress
Number of subjects: 1944

Group type: EXPERIMENTAL
Intervention: Unmet social needs
Number of subjects: 1944

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 1944